Company
Pulmocide
Developing targeted therapies for serious respiratory diseases
Also known as Pulmocide Limited
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- Pulmocide Limited
Claim, correct or request removal
Record updated 28 September 2026
About
Pulmocide is a biopharmaceutical company that specializes in tackling difficult-to-treat respiratory diseases.
Funding snapshot
- Total raised
- $52MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Undisclosed, $52M2022-12-06
Funding rounds
- Round, 2022
- $52M2022-12-06, Company stated
- Round, 2021
- 2021-12-21
Products
- Other
- Opelconazole
- Web
- Opelconazole
Loading relationship preview